Innoviva develops respiratory pharmaceuticals through strategic partnerships and royalty agreements in the global healthcare market.
Zacks Investment Research on MSN
Why is Glaxo (GSK) down 2.1% since last earnings report?
It has been about a month since the last earnings report for GSK (GSK). Shares have lost about 2.1% in that time frame, underperforming the S&P 500. But investors have to be wondering, will the recent ...
South Wales Argus on MSN
Three-bed semi detached house hits market on well-regarded road
A three-bedroom semi-detached home on Leicester Road, Newport, has gone up for sale.
As Asian markets navigate a complex landscape marked by geopolitical tensions and fluctuating economic indicators, investors are increasingly focused on identifying opportunities that offer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results